Teriparatide promotes healing of critical size femur defect through accelerating angiogenesis and degradation of beta-TCP in OVX osteoporotic rat model
Teriparatide promotes healing of critical size femur defect through accelerating angiogenesis and degradation of beta-TCP in OVX osteoporotic rat model
复制标题
特立帕肽通过加速 OVX 骨质疏松大鼠模型中血管生成和 β-TCP 降解来促进临界尺寸股骨缺损的愈合
DOI:
10.1016/j.biopha.2017.11.141
复制
发表时间:
2017
影响因子:
7.5
通讯作者:
Yang Lei
中科院分区:
文献类型:
--
作者:
Xie Zhongjie;Weng Sheji;Li Hang;Yu Xia;Lu Shanshan;Huang Kate;Wu Zongyi;Bai Bingli;Boodhun Viraj;Yang Lei
Accumulating evidence suggests that early angiogenesis has an important effect on the healing of injury. Teriparatide (PTH) is extensively applied for its potent anabolic activity on bone, while little is known about its angiogenic ability which may facilitate new bone formation. In this study, we tested the angiogenic ability of PTH and its effect on degradation of β-tricalcium phosphate (β-TCP) in an ovariectomized (OVX) rat distal femoral metaphysis model. After successful establishment of the OVX model was confirmed, a critical size defect was drilled into each distal femur of the OVX rats. Afterwards all animals were randomly divided into three groups: control group, group β-TCP and group β-TCP+PTH, then rats of group β-TCP+PTH were injected Teriparatide (30 μg/kg) subcutaneous every other day. Four weeks after femur surgery, five specimens from each group were used for Microfil perfusion to reveal blood vessels in the bone defect. The residual rats were harvested for micro-computed tomography, histological analysis and immunochemistry. The results showed Teriparatide facilitated neovascularization, degradation of β-TCP and new bone formation in combination with β-TCP, which may be relevant to neovascularization in an early phase.